Cut7 is a plus-end-directed kinesin motor protein critical for mitosis. It facilitates spindle pole separation by sliding antiparallel microtubules, ensuring bipolar spindle assembly . Unlike other kinesin-5 proteins, Cut7 exhibits bidirectional motility along microtubules . It also regulates γ-tubulin ring complex (γ-TuRC) activity at spindle poles, antagonizing the kinesin-14 Pkl1 to balance microtubule nucleation .
Key findings from truncation mutants of Cut7’s N-terminal extension:
| Mutant | Viability | Localization | Microtubule Binding |
|---|---|---|---|
| Wild-type | Viable | Spindle poles | Normal |
| ΔN1 | Non-viable | Disrupted | Reduced |
| ΔN2 | Viable | Normal | Unaffected |
ΔN1 mutants fail to grow post-promoter shutoff, indicating the N-terminal extension’s necessity for stability or function .
ΔN2 retains viability but shows altered microtubule interaction kinetics .
Cut7 regulates Argonaute 1 (Ago1)-containing ribonucleoprotein (RNP) complexes:
Genetic screen data: Cut7 depletion reduces Ago1-RNP biogenesis/stability .
Interaction assays: Cut7 co-immunoprecipitates with Ago1, suggesting direct involvement in RNP transport along microtubules .
While no commercial Cut7-specific antibodies are detailed in the search results, studies employ epitope-tagged constructs (e.g., GFP) and immunodetection:
Western blotting: Anti-GFP antibodies verify Cut7-3xGFP expression in S. pombe strains .
Localization assays: Fluorescence microscopy with mCherry-tubulin reveals Cut7’s spindle-associated distribution .
Though not directly applied to Cut7 in the provided data, CUT&RUN (Cleavage Under Targets and Release Using Nuclease) is a high-resolution method for mapping protein-DNA interactions . Potential applications for Cut7 could include studying its role in chromatin-associated processes.
| Feature | Cut7 (S. pombe) | Human Kinesin-5 (Eg5) |
|---|---|---|
| Motility Direction | Bidirectional | Plus-end-only |
| Mitotic Role | Spindle assembly | Chromosome segregation |
| Regulatory Partners | γ-TuRC, Pkl1 | TPX2, Aurora A kinase |
Essentiality: Cut7 loss causes monopolar spindles and mitotic failure .
Dosage sensitivity: Overexpression disrupts microtubule dynamics, highlighting stoichiometric constraints .
Evolutionary conservation: Functional parallels with budding yeast Cin8 and human Eg5 underscore its conserved role in mitosis .
KEGG: mtu:Rv1984c
STRING: 83332.Rv1984c
Cut7 is a kinesin-5 motor protein in fission yeast that plays an essential role in bipolar spindle formation during cell division. The gene is critical for cell viability, as demonstrated in shutoff experiments where cells lacking functional cut7 form monopolar spindles rather than bipolar spindles . Cut7 contains an N-terminal extension region with properties of intrinsic disorder, which influences its molecular function. Understanding cut7's role provides insights into fundamental cellular processes involving microtubule dynamics and mitosis.
Based on published research, fluorescence microscopy using GFP-tagged cut7 constructs has proven effective for studying cut7 localization. In the referenced study, researchers visualized Cut7-3xGFP alongside mCherry-tubulin to examine microtubule association patterns . For immunodetection of native cut7, indirect immunofluorescence using primary antibodies specific to cut7 followed by fluorophore-conjugated secondary antibodies would be recommended, with careful optimization of fixation and permeabilization conditions to preserve spindle structure.
While specific data for cut7 is limited in the provided sources, fixation protocol selection significantly impacts antibody accessibility to cut7 epitopes. For spindle-associated proteins like cut7:
As noted in CUT&RUN literature, fixation can cause artifacts and antigen masking , suggesting that optimizing fixation conditions is critical for accurate cut7 detection.
For rigorous validation of cut7 antibodies, implement multiple complementary approaches:
Genetic controls: Use cut7 deletion or depletion strains as negative controls. The referenced study employed an inducible nmt81 promoter system to shut off cut7 expression, creating a controlled comparison for antibody specificity testing .
Western blot validation: Compare signal patterns between wild-type and mutant forms. The researchers in the provided study examined expression of various Cut7 constructs by western blot analysis using an anti-GFP antibody, ensuring equal amounts of total protein per lane .
Immunofluorescence correlation: Confirm that the antibody signal colocalizes with expected spindle structures. The published work demonstrated that Cut7-3xGFP properly localized to microtubules as visualized by mCherry-tubulin .
Pre-absorption controls: Pre-incubate your antibody with purified cut7 antigen before immunostaining to confirm signal reduction.
The N-terminal extension of cut7 contains regions of intrinsic disorder that influence function and potentially antibody accessibility . When designing truncation mutants for epitope mapping:
Preserve functional domains: The study demonstrated that different N-terminal truncations (ΔN1 vs. ΔN2) had distinct effects on cell viability, indicating functional importance of specific regions .
Consider protein folding effects: Truncations may alter tertiary structure and epitope presentation.
Include GFP or similar tags for detection controls: The referenced work used GFP fusion constructs to monitor expression and localization .
Validate mutant stability: Confirm that truncated proteins reach sufficient expression levels for detection, as demonstrated in the western blot analysis in the study .
Assess localization patterns: The researchers verified that their constructs localized properly through fluorescence microscopy, which is essential for interpreting antibody binding results .
For robust cut7 immunoprecipitation experiments:
Include IgG control: Similar to the approach mentioned in CUT&RUN methods, include a non-specific IgG antibody as a negative control to identify non-specific binding .
Validate with known interactors: Include detection of established cut7 binding partners.
Consider "blacklist" interactions: As discussed in CUT&RUN literature, certain regions consistently show background signal across experiments . Similarly, prepare for non-specific interactions in cut7 IP experiments.
Implement reciprocal IPs: If studying cut7 interactions with a specific protein, perform IPs in both directions.
Use cut7 depletion strains: The thiamine-regulated nmt81 promoter system described in the study provides a controlled way to reduce cut7 expression for negative control samples .
Several factors can contribute to background when imaging cut7:
Non-specific antibody binding: Similar to issues discussed in CUT&RUN controls, where researchers compiled "blacklists" of suspicious regions showing signal across multiple samples including IgG controls .
Autofluorescence from fixatives: Particularly with glutaraldehyde fixation of yeast cells.
Inadequate blocking: Microtubule-dense regions may require optimized blocking conditions.
Secondary antibody cross-reactivity: Test secondary antibodies alone to identify potential direct binding to yeast components.
Permeabilization artifacts: Excessive permeabilization can disrupt spindle architecture and create artifacts.
To minimize background, implement sequential blocking steps and include appropriate absorption controls, as would be recommended for sensitive detection methods like CUT&RUN .
When detecting potentially low-abundance cut7:
Titrate antibody concentrations: Begin with manufacturer recommendations and test serial dilutions.
Extend incubation times: Consider overnight incubation at 4°C to maximize binding.
Employ signal amplification: Use biotin-streptavidin systems or tyramide signal amplification if necessary.
Reduce cell/nuclei numbers: The CUT&RUN literature notes that assays can be performed with as few as 5,000 cells for histone marks and 25,000 cells for transcription factors . While cut7 detection might require different optimization, this illustrates the importance of cell number optimization.
Compare cells vs. nuclei preparations: Similar to findings in CUT&RUN experiments where "filtered peaks remain higher at lower input for nuclei than cells" , consider whether isolated nuclei might provide cleaner results than whole cells for nuclear-associated cut7 detection.
When facing discrepancies between detection methods:
Evaluate epitope accessibility: The 3D conformation of cut7 differs between denatured (western blot) and native (immunofluorescence) states. The N-terminal extension of cut7, with its intrinsically disordered regions , may present different epitopes under different conditions.
Assess fixation effects: Test multiple fixation protocols as different methods may preserve different cut7 conformational states.
Compare wild-type and mutant signals: The truncation mutants described in the study could help identify which regions contribute to detection discrepancies.
Verify antibody specificity in each method: Some antibodies perform well in one application but poorly in others.
Consider post-translational modifications: Different cellular pools of cut7 may carry different modifications that affect antibody recognition.
For studying cut7 interaction networks:
Proximity-based labeling: Couple cut7 antibodies with enzymatic tags for proximity labeling of interaction partners.
Co-immunoprecipitation with mass spectrometry: Use cut7 antibodies for pulldown followed by MS identification of associated proteins, while applying filtering criteria similar to those used in CUT&RUN "blacklist" development to minimize false positives .
In situ proximity ligation assay (PLA): Detect interactions between cut7 and candidate partners with single-molecule resolution in fixed cells.
Fluorescence microscopy co-localization: The reference study demonstrated the utility of fluorescently tagged cut7 (Cut7-3xGFP) alongside mCherry-tubulin for localization studies , which could be extended to study additional factors.
Chromatin-association analysis: While cut7 is primarily a motor protein, any potential chromatin associations could be studied using adapted CUT&RUN protocols, which provide better resolution than ChIP-Seq .
For live-cell applications with cut7:
Antibody fragment optimization: Convert conventional antibodies to Fab or nanobody formats to improve cellular penetration.
Validate functionality impact: Ensure that antibody binding doesn't interfere with cut7's motor function or interactions.
Compare with fluorescent protein fusions: Benchmark antibody-based detection against the established Cut7-3xGFP system described in the literature .
Implement photobleaching controls: Distinguish between true signal dynamics and imaging artifacts.
Establish optimal expression levels: As demonstrated in the cut7 shutoff experiments, expression level significantly impacts spindle formation and cell viability , making careful calibration essential.
While cut7 is primarily characterized as a motor protein rather than a chromatin-associated factor, investigating potential chromatin interactions would require special considerations:
Modified cell preparation: Adapt the CUT&RUN cell immobilization protocol to preserve potential transient interactions between spindle components and chromatin .
Protocol optimization for low cell numbers: The CUT&RUN method's compatibility with as few as 5,000 cells makes it potentially suitable for studying cut7 in rare cell populations or specific cell cycle stages.
Selective targeting of spindle-associated chromatin: Use cut7 antibodies in conjunction with chromatin-associated protein antibodies.
Compare with IgG controls: As emphasized in CUT&RUN protocols, rigorous IgG controls are essential to distinguish genuine signal from background .
Employ cross-validation: Compare any potential chromatin associations identified with other methods such as ChIP-seq, while recognizing that "CUT&RUN does not require fixation" and may capture different interaction profiles .
For robust quantification of cut7 localization:
Implement unbiased image segmentation: Define spindle regions algorithmically rather than manually.
Compare signal-to-background ratios: Calculate the ratio between spindle-localized cut7 signal and cytoplasmic background.
Apply colocalization metrics: Quantify the degree of overlap between cut7 and microtubule signals, similar to the visualization of Cut7-3xGFP and mCherry-tubulin described in the reference .
Construct intensity profiles: Generate line scans across spindle structures to analyze cut7 distribution patterns.
Employ statistical tests appropriate for non-normal distributions: Intensity data often follows non-Gaussian distributions requiring non-parametric statistical approaches.
For temporal analysis of cut7 dynamics:
Implement cell cycle staging: Use established markers to classify cells by mitotic phase.
Develop quantitative metrics: Measure spindle length, cut7 intensity, and distribution patterns at each stage.
Consider 3D reconstruction: Account for the three-dimensional nature of spindle structures.
Track individual cells: For time-lapse experiments, implement cell tracking algorithms to follow individual cells through division.
Correlate with functional outcomes: Compare cut7 patterns with spindle dynamics and cell viability, similar to the growth curve analysis performed for cut7 mutants in the reference study .